Free Trial

Citigroup Upgrades Bridgepoint Group (LON:BPT) to Buy

Bridgepoint Group logo with Financial Services background
Remove Ads

Bridgepoint Group (LON:BPT - Get Free Report) was upgraded by equities research analysts at Citigroup to a "buy" rating in a research report issued on Thursday, Marketbeat reports. The firm currently has a GBX 410 ($5.30) target price on the stock. Citigroup's target price indicates a potential upside of 22.24% from the company's current price.

Bridgepoint Group Price Performance

Shares of BPT traded up GBX 7 ($0.09) on Thursday, reaching GBX 335.40 ($4.33). The stock had a trading volume of 419,922 shares, compared to its average volume of 3,893,947. Bridgepoint Group has a twelve month low of GBX 202.40 ($2.62) and a twelve month high of GBX 410 ($5.30). The firm has a market capitalization of £2.77 billion, a PE ratio of 60.93, a PEG ratio of 0.61 and a beta of 1.72. The firm has a 50-day moving average of GBX 358.96 and a 200 day moving average of GBX 347.22. The company has a quick ratio of 3.60, a current ratio of 4.98 and a debt-to-equity ratio of 12.89.

Bridgepoint Group (LON:BPT - Get Free Report) last posted its earnings results on Thursday, March 13th. The company reported GBX 19.50 ($0.25) earnings per share for the quarter. Bridgepoint Group had a return on equity of 6.10% and a net margin of 16.74%. Sell-side analysts expect that Bridgepoint Group will post 17.4062165 EPS for the current year.

Remove Ads

About Bridgepoint Group

(Get Free Report)

Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.

See Also

Should You Invest $1,000 in Bridgepoint Group Right Now?

Before you consider Bridgepoint Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bridgepoint Group wasn't on the list.

While Bridgepoint Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Quantum Stocks Are Heating Up Again — 7 to Watch Now
Stock Market on Sale – Buy Now Before the Next Big Surge
Google’s $32B Move: 3 Cybersecurity Stocks to Watch

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads